Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Locally advanced or metastatic urothelial cancer · Nectin-4 Expressing Advanced Malignancies. · BCYC

BICYCLE THERAPEUTICS

BICYCLE THERAPEUTICS patent portfolio — 57 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Cambridge, GB HQ
2009 Founded
282 Employees
Public company Type
BCYC · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, GB
Founded
2009
Employees
282
Programs
8
Drugs
15
Patents
57
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

BICYCLE THERAPEUTICS patents

57 pharmaceutical patents indexed for BICYCLE THERAPEUTICS. 0 expire within 24 months.

BICYCLE THERAPEUTICS has 57 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

57 patents

Patent portfolio

Page 1 of 2

  1. US 12377155

    Bicyclic peptide ligands specific for PSMA

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12378288

    Multimeric bicyclic peptide ligands

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12350343

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12318454

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12150998

    Bicyclic peptide ligands specific for P-selectin

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12049520

    Bicyclic peptide ligands specific for CD137

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11970555

    Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11970553

    Heterotandem bicyclic peptide complex

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11912792

    Bicyclic peptide ligands specific for nectin-4

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11912794

    Modulation of structured polypeptide specificity

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11904020

    Bicyclic peptide ligands specific for TREM2

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11866518

    Bicyclic peptide ligands specific for TSLP

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11833211

    Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11814447

    Peptide ligands for binding to EphA2

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11753444

    Modulation of structured polypeptide specificity

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11746126

    Bicyclic peptide ligands with detectable moieties and uses thereof

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11730819

    Peptide derivatives having novel linkage structures

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11696956

    Bicyclic peptide ligands specific for EphA2

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11672868

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11623012

    Bicyclic peptide ligands specific for EphA2

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11613560

    Bicyclic peptide ligands specific for OX40

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11542304

    Multimeric bicyclic peptide ligands

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11484602

    Bicyclic peptide ligands specific for EphA2

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11453703

    Heterotandem bicyclic peptide complexes

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11453702

    Bicyclic peptide ligands specific for Nectin-4

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11433137

    Compounds for treating cancer

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11414488

    Methods for treating cancer

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11396530

    Bicyclic peptide ligands and uses thereof

    Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11332500

    Heterotandem bicyclic peptide complexes

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11312749

    Heterotandem bicyclic peptide complex

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11306123

    Heterotandem bicyclic peptide complex

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11261214

    Bicyclic peptide ligand specific for CD137

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11241473

    Bicyclic peptide ligands and uses thereof

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11180531

    Bicyclic peptide ligands specific for Nectin-4

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11103591

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10994019

    Bicyclic peptide-toxin conjugates specific for MT1-MMP

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10919937

    Bicyclic peptide ligands and uses thereof

    Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10899798

    Bicyclic peptide ligands with detectable moieties and uses thereof

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10894808

    Polypeptide ligands specific for plasma kallikrein

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10875894

    Multimeric bicyclic peptide ligands

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10870679

    Modulation of structured polypeptide specificity

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10857196

    Bicyclic peptide ligands and uses thereof

    Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10800813

    Modulation of structured polypeptide specificity

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10792368

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10624968

    Compounds for treating cancer

    Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10532106

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10441663

    Methods for treating cancer

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10294274

    Polypeptide ligands specific for plasma kallikrein

    Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does BICYCLE THERAPEUTICS have?

57 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BICYCLE THERAPEUTICS patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.